StockWatch
·

Research Reports

08 Aug 2026
AMANTAAmanta Healthcare Ltd

Revenue on track, profit delayed — overhead absorption masks the Q1 story

SteriPort · capacity-delay · overhead-absorption

Result verdictFollow-upQ1 FY276 minPharma & Healthcare
AMANTAAmanta Healthcare Ltd

SteriPort delays weigh Q1; strong multi-year visibility

capacity-delay · polymer-absorption · FY28-targets

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
AKUMSAkums Drugs and Pharmaceuticals Ltd

Akums Q1FY27: consolidated PAT surges 56% YoY to ₹101 Cr as margins expand, exports miss

cdmo growth · margin expansion · api losses narrowing

ResultsQ1 FY273 minPharma & Healthcare
PARKHOSPSPark Medi World Ltd

Steady execution amid capacity dilution; long-term roadmap raised

acquisition integration · occupancy recovery · CGHS benefit

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.

NATCO Pharma Q1 FY27: The Trough Year Begins—Revlimid Cliff and Specialty Ramp

NATCO Pharma · Revlimid cliff · trough year

Result previewQ1 FY273 minPharma & Healthcare
IPCALABIPCA LABORATORIES LTD.

Sustaining double-digit growth through a transformative year

IPCA · pharma · Q1 results

Result previewQ1 FY273 minPharma & Healthcare
ALKEMAlkem Laboratories Ltd

Mid-year tracking: margin defense amid FDA headwinds

pharma · generics · US exports

Result previewQ1 FY273 minPharma & Healthcare
07 Aug 2026
AARTIPHARMAarti Pharmalabs Ltd

Aarti Pharmalabs Q1FY27: consolidated PAT +65% YoY to ₹76 Cr as OPM expands to 25.4%

cdmo growth · margin expansion · capex approval

ResultsQ1 FY273 minPharma & Healthcare
JSLLJeena Sikho Lifecare Ltd

Jeena Sikho Q1 FY27: PAT +29% YoY on consolidated basis, but core margin slips 416bps

ayurveda healthcare · product segment growth · operating margin compression

ResultsQ1 FY273 minPharma & Healthcare
KOVAIKOVAI MEDICAL CENTER & HOSPITAL LTD.

Kovai Medical Q1 FY27: standalone PAT +21% YoY to ₹69 Cr as margins expand

hospital services · margin expansion · healthcare segment

ResultsQ1 FY273 minPharma & Healthcare
ENTEROEntero Healthcare Solutions Ltd

Entero Healthcare Q1FY27: consolidated PAT +72% YoY to ₹52 Cr, OPM hits 5% target

pharma distribution · margin expansion · acquisition led growth

ResultsQ1 FY273 minPharma & Healthcare
ANUHPHRANUH PHARMA LTD.

Anuh Pharma Q1FY27: PAT jumps 38% YoY on margin expansion, revenue growth tepid at 4%

pharma · bulk drugs · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
HEALTHXSastasundar Ventures Ltd

Health X Platform: revenue jumps 50% YoY but consolidated PAT crashes 93% to ₹2 Cr

healthcare network · margin compression · segment loss

ResultsQ1 FY273 minPharma & Healthcare
CONCORDBIOConcord Biotech Ltd

Strong 26% growth, margin expansion; long-term bets ramping slower than guided

export momentum 46% · pricing power · injectable facility 5% util.

TranscriptDeep diveQ1 FY276 minPharma & Healthcare
GUJTHEMGUJARAT THEMIS BIOSYN LTD.

Gujarat Themis Biosyn Q1 FY27: consolidated PAT up 22% YoY to ₹11.07 Cr as OPM expands 870bps

pharma intermediates · api manufacturing · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
ABBOTINDIAABBOTT INDIA LTD.

Chronic therapies to anchor steady growth; margin resilience key watch

Abbott India · pharma · Q1 FY27

Result previewQ1 FY273 minPharma & Healthcare
ZYDUSLIFEZydus Lifesciences Ltd

Margin Headwinds Test the Guidance — Zydus Q1 in Focus

earnings preview · Q1 FY27 · Zydus Lifesciences

Result previewQ1 FY273 minPharma & Healthcare
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LTD.

Demerger catalyst and hospital biz acceleration into focus

hospital · demerger · occupancy

Result previewQ1 FY273 minPharma & Healthcare
06 Aug 2026
SAILIFESai Life Sciences Ltd

Sai Life Sciences Q1 FY27: consolidated PAT up 21% YoY to ₹73 Cr as margins expand

crdmo · pharma cdmo · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
LUPINLUPIN LTD.

Lupin Q1 FY27: PBT +43% YoY beats Street; PAT growth muted by tax normalization

pharmaceuticals · acquisition integration · tax normalization

ResultsQ1 FY273 minPharma & Healthcare
VIJAYAVijaya Diagnostic Centre Ltd

Vijaya Diagnostic Q1FY27: PAT +37.6% YoY on margin expansion, revenue up 22.8%

diagnostics · margin expansion · pat growth

ResultsQ1 FY273 minPharma & Healthcare
JENBURPHJENBURKT PHARMACEUTICALS LTD.

Jenburkt Q1 FY27: PAT falls 24% YoY as staff costs surge, margins compress

pharmaceuticals · margin compression · employee costs

ResultsQ1 FY273 minPharma & Healthcare
HCGHealthCare Global Enterprises Ltd

HCG Q1 FY27: consolidated PAT up 175% YoY to ₹16.5 Cr as NPM more than doubles to 2.4%

oncology hospitals · margin expansion · npm improvement

ResultsQ1 FY273 minPharma & Healthcare
HIKALHIKAL LTD.

Hikal Q1FY27: consolidated loss narrows to ₹7.4 Cr YoY as margins expand, revenue up 6%

specialty chemicals · pharma segment · crop protection

ResultsQ1 FY273 minPharma & Healthcare
ALBERTDAVDALBERT DAVID LTD.-$

Albert David Q1 FY27: standalone PAT surges 303% YoY to ₹32 Cr as margins expand sharply

pharmaceuticals · margin expansion · tax credit

ResultsQ1 FY273 minPharma & Healthcare
PGHLProcter & Gamble Health Ltd

P&G Health Q1: revenue +7% YoY but core PAT down ~3% adjusted for one-off land-sale gain

pharmaceuticals · one-off gain · asset sale

ResultsQ1 FY273 minPharma & Healthcare
ZIMLABZim Laboratories Ltd

Zim Labs' consolidated loss widens to ₹4.02 Cr in Q1 FY27 as margins compress

pharmaceuticals · generics · eu gmp

ResultsQ1 FY273 minPharma & Healthcare
EMCUREEmcure Pharmaceuticals Ltd

Emcure Q1FY27: consolidated PAT up 36% YoY to ₹292 Cr, margins expand, revenue +23%

pharma exports · margin expansion · international revenue growth

ResultsQ1 FY273 minPharma & Healthcare
SUVENSUVEN LIFE SCIENCES LTD.

Consolidated loss widens 148% YoY to ₹127.6 Cr as R&D spend surges on Phase 3 trials

clinical stage biopharma · phase 3 trial · r&d expense surge

ResultsQ1 FY273 minPharma & Healthcare
05 Aug 2026
AUROPHARMAAUROBINDO PHARMA LTD.

Aurobindo Q1 FY27: consolidated PAT +25% YoY to ₹1,032 Cr as margins near 21% target

pharma · consolidated results · margin expansion

ResultsQ1 FY273 minPharma & Healthcare